GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Pre-Tax Income

FibroBiologics (STU:SG0) Pre-Tax Income : €-20.74 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. FibroBiologics's pretax income for the three months ended in Mar. 2024 was €-7.78 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-20.74 Mil. FibroBiologics's pretax margin was %.


FibroBiologics Pre-Tax Income Historical Data

The historical data trend for FibroBiologics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Pre-Tax Income Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Pre-Tax Income
-1.40 -4.83 -15.12

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -2.26 -2.00 -2.05 -8.91 -7.78

Competitive Comparison of FibroBiologics's Pre-Tax Income

For the Biotechnology subindustry, FibroBiologics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroBiologics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Pre-Tax Income falls into.



FibroBiologics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

FibroBiologics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-8.151+-6.831+-0.135+0+0
=-15.12

FibroBiologics's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.174+-4.641+-0.004+0.036+0
=-7.78

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-20.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics  (STU:SG0) Pre-Tax Income Explanation

FibroBiologics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-7.783/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (STU:SG0) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (STU:SG0) Headlines

No Headlines